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A BST R AC T   
 
Aim: Migralepsy is a clinical entity that occasionally represents a diagnostic problem. An apparent 
history and clinical manifestation of migraine may mask the epileptic attack accompanying 
migralepsy. The aim of this study is to present our experience with clinical and 
electroencephalography (EEG) findings and treatment of our patients diagnosed with childhood 
migralepsy disease. 
Methods: We documented six patients who were initially followed-up with a diagnosis of migraine, 
subsequently observed to have epileptic seizures, and then diagnosed with migralepsy. 
Result: Our patients became asymptomatic by giving good responses to antiepileptic therapy based 
on clinical and electroencephalography (EEG) findings. 
Conclusions: This case series shows that EEG recording can be useful in all stages of migraine for 
long-term, safe monitoring. Identifying patients with possible migralepsy will enable them to receive 
antiepileptic treatment. 
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Introduction 
The term migralepsy derives from a 
combination of the words migraine and 
epilepsy [1]. The condition is defined as a 
migraine-triggered seizure [2]. The 
relationship between the two clinical 
conditions is a complex one. 
Migralepsy is not included in the classification 
of epilepsy while taking part in headache 
classification. According to ICHD-III beta 
1.5.5, migralepsy constitutes a seizure 
triggered by a migraine aura [3]. ICHD-III 
diagnostic criteria for migralepsy are as 
follows: A,  a seizure meeting diagnostic 
criteria for one type of epileptic attack, B, 
occurring in a patient with 1.2 migraine with 
aura, and during or within 1 hour of an attack 
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of migraine with aura, C. not better accounted 
for by another diagnosis[1].  
The prevalence of migraine among epilepsy 
patients is 7-26%, while that of epilepsy 
among migraine patients is 1-17% [4,5]. In 
both cases there is evidence to support the 
hypothesis that migraine and epilepsy are 
comorbid states. A common underlying 
mechanism has been suspected, because many 
patients have been observed to experience 
seizures and headaches. Mitochondrial 
diseases, especially MELAS (Mitochondrial 
Myopathy, Encephalopathy, Lactic Acidosis 
and Stroke-like episodes) and mitochondrial 
DNA polymerase gene (POLG1) mutations, 
can present with both epilepsy and migraine. In 
MELAS, the posterior cerebral region is 
affected in patients with epilepsy, while 
POLG1 mutations cause the occipital lobe to 
be affected. Damage in these areas may cause 
migraine to develop [6,7]. Another 
mechanism, cortical spreading depression 
(CSD), was first proposed by Lashley in 1941 
[2,3]. Release of glutamate by glial cells was 
recognized as triggering CSD in the 1970s [8]. 
Although the mechanism and spread of CSD is 
not yet fully understood, hyper-excitability and 
synchronicity are regarded as the common 
basic mechanism in epilepsy and migraine. 
Seizure discharges in the occipital lobes are 
assumed to trigger an actual migraine 
headache through CSD without other 
associated cortical epileptic signals, leading to 
the activation of the trigeminovascular system 
or brainstem mechanisms, as previously 
described [9].  
The term migralepsy was introduced by 
Lennox & Lennox (1960) to describe a 
condition in which ‘‘ophthalmic migraine (= 
migraine with aura) is followed by symptoms 
characteristic of epilepsy’’ [8]. Since then, 
there have been only 60-70 reports of cases of 
migralepsy [4,10,11]. Most of these involved 
adult patients. The aim of this study is to 
present our experience with clinical and 
electroencephalography (EEG) findings and 
treatment of our patients diagnosed with 
childhood migralepsy disease. 
 
Methods 
We evaluated the clinical and EEG findings of 
six patients diagnosed with migralepsy based 
on migraine ICD-III beta criteria in the 
pediatric neurology clinic between January 
2015 and August 18. Clinical and EEG 
findings were obtained from patients’ hospital 
records. Patients with a history of seizures 
during migraine attacks were included in the 
study. Patients with migraine or epilepsy only, 
with ictal epileptic headache or with postictal 
headache were excluded. In addition, brain 
magnetic resonance imaging (MRI) findings of 
all patients were also obtained. Ethics 
committee approval for the study was obtained 
from Bolu Abant Izzet Baysal University 
Clinical Research Ethics Committee (No. 
2018/129). All procedures performed in 
studies involving human participants were in 
accordance with the ethical standards of the 
institutional and/or national research 
committee and with the 1964 Helsinki 
declaration and its later amendments or 
comparable ethical standards.  This article does 
not contain any studies with animals 
performed by any of the authors.  
 
Results 
Our patient data are shown in Table 1. Four of 
our patients were girls (9-16 years) and two 
were boys (aged 10 and 14 years). All patients 
had epileptic seizures with migraine headaches 
without aura. Two patients had a family history 
of epilepsy (patients 1 and 4), and two had a 
family history of migraine (patients 2 and 3). 
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All patients responded poorly to classic 
migraine treatment (flunarizine, propranolol 
etc.).  
Physical & neurological examinations 
(including ophthalmological examination) and 
hematological and biochemical laboratory 
findings were normal. Since EEG video-
monitoring is not available in our clinic, we 
performed interictal EEGs, which were either 
abnormal or epileptiform (Table 1 and Figure 
1). MRI of the brain was normal in all patients.  
Patients with migraine and epileptic seizures 
were evaluated for migralepsy, and 
antiepileptic treatment was initiated.  
Clinical and EEG responses to antiepileptic 
treatment were very good. Our patients are still 
being monitored after one to four years.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Discussion 
Migralepsy was first described by Lennox & 
Lennox [1,2,8]. Migraine with aura was 
reported in three cases, involving focal seizure 
in one and generalized seizure in two in the 
aura period [12].  These presentations then 
continued as case series [13,17].  
Epileptic attacks were accompanied by 
migraine aura or headache periods in these 
studies [13]. EEG findings exhibit variations in 
migralepsy cases and series in the literature. 
Anderman et al reported eight cases with 
generalized tonic clonic seizures during the 
aura period; two cases of interictal EEG were 
normal, the others exhibiting spike and sharp 
wave activities in the T (temporal) and O 
(occipital) regions [12]. Niedermeyer and et al  
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reported eight cases of generalized tonic clonic 
seizures in the migraine aura period regarded 
as possible migralepsy [14]. In another study, 
13 cases, mostly with focal convulsions in the 
migraine aura period, exhibited abnormal ictal 
and interictal EEGs [15]. In one study, periodic 
lateralized epileptiform discharges were 
mainly seen on ictal EEGs in seven cases with 
focal feature seizures [16]. Migralepsy cases 
occur as migraine aura-induced seizures in 
adult patients [16]. A four-year-old with 
emotional stress-induced migralepsy was 
described in one report [11]. Most cases in the 
literature consist of adult patients with 
migraine with aura. Rarely, there are cases of 
migralepsy diagnosed as migraine without aura 
[14,17,18]. 
 
Figure 1. EEG of patient 2 showing generalize 
multiple spike-wave activity and burst pattern 
occurring in stage II sleep. 
 
 
 
 
 
 
 
 
 
As seen in the previous literature and in our 
patients, migralepsy is a clinical entity that 
sometimes poses a diagnostic problem. A 
distinct history of migraine and its clinical 
manifestation may mask the accompanying 
epileptic episode. Headache may have an aura, 
ictal pattern or be a postictal sign of epileptic 
seizures. Re-evaluation of patients who do not 
respond well to migraine treatment and EEG 
recording may be considered. Diagnosis of 
migralepsy may be delayed until manifest 
epileptic seizures occur in these patients. 
Our patients were diagnosed with migraine and 
did not respond well to treatment. Epileptic 
seizures occurring during follow-up suggested 
a diagnosis of migralepsy, which we confirmed 
with EEGs. The most important characteristic 
feature of our patients was migralepsy without 
aura. Cases of migralepsy without aura have 
also been reported previously [14,17,18]. 
The two most important limitations of our 
study are that diagnosis of migralepsy was not 
supported by video EEG monitoring, and the 
low number of cases.  Future large series 
studies might perform video EEG recording in 
patients with migraine, including symptomatic 
and asymptomatic headache processes. This 
will make it possible to document the potential 
epileptic character of all stages of migraine. 
To summarize, in the light of previous reports 
and our own cases; i) migraine should be very 
carefully differentiated from all other 
neurological paroxysmal disorders, including 
epileptic seizure, ii) EEG recording can be 
useful for long-term safe monitoring in all 
stages of migraine, iii) abnormal or 
epileptiform EEG records may also be 
valuable in terms of the possibility of 
migralepsy, and iv) migraine patients who do 
not respond sufficiently to treatment may 
perhaps be suitable for antiepileptic therapy 
treatment if indicated by the EEG findings.  
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